Dimethylamine. 1 Toxic Effects and Modes of Action. 1.1 Nitrosamine formation. Classification/MAK value: 4mg/m 3. MAK value dates from: 1993

Size: px
Start display at page:

Download "Dimethylamine. 1 Toxic Effects and Modes of Action. 1.1 Nitrosamine formation. Classification/MAK value: 4mg/m 3. MAK value dates from: 1993"

Transcription

1 Dimethylamine Classification/MAK value: MAK value dates from: 1993 Chemical name (CAS): 2 ml/m 3 (ppm) 4mg/m 3 CAS number: N-methylmethanamine Structural formula: H 3 C NH CH 3 Molecular formula: C 2 H 7 N Molecular weight: Melting point: 93 C Boiling point: C 1 ml/m 3 (ppm) = 1.87 mg/m 3 1mg/m 3 = ml/m 3 (ppm) 1 Toxic Effects and Modes of Action Dimethylamine is a colourless inflammable gas with a strongly ammoniacal odour. It is readily soluble in water and more basic than ammonia. Because of its good solubility in lipids, dimethylamine is readily and rapidly absorbed in the gastrointestinal and respiratory tracts. Concentrated dimethylamine vapour is highly irritating to mucous membranes. Absorbed dimethylamine is a central nervous system depressant; the mechanism of this action has not been studied in detail. A long-term inhalation study with rats and mice produced no evidence of a carcinogenic potential. Numerous mutagenicity studies in which the substance was tested without added nitrite yielded negative results. One teratogenicity study has been carried out in mice; the results were negative. Liquid dimethylamine readily penetrates the skin; the skin penetration of the vapour has not been studied. Sensitizations caused by dimethylamine in man have not been reported to date. 1.1 Nitrosamine formation In the presence of nitrite or nitrous gases, dimethylamine is converted to dimethylnitrosamine. Since dimethylamine is highly basic, the yield of nitrosamine is low. The ph optimum for the reaction is about 3.0; this suggests that nitrosation could take place in the stomach after simultaneous intake of amine and nitrite. Nitrosamine formation in

2 76 Dimethylamine Volume 7 vivo has been demonstrated in mice given oral doses of dimethylamine and nitrite (Iqbal et al. 1981) and after intubation with dimethylamine followed by inhalation of NO 2 (Iqbal 1986). In studies in which rats or mice were given oral doses of dimethylamine (1 mg/kg body weight) and sodium nitrite (50 mg/kg body weight), about 0.8 % of the dimethylamine dose was nitrosated. Simultaneous administration of 50 mg vitamin C or 50 mg vitamin E reduced the nitrosation by 80 % and 50 %, respectively (Meier-Bratschi et al. 1983). It may be assumed that similar nitrosation conditions are found in man but that because the nitrite levels in the human stomach are normally low, only low levels of nitrosamine are formed. The significance of endogenous nitrosation is still unclear. Dimethylnitrosamine is also formed in reactions between dimethylamine and nitrogen oxides in the gas phase. The nitrosamine, which is stable in the dark and behind window glass, is formed in yields of 1 % to 3 % (Glasson 1979, Pitts et al. 1978). In sunlight it is decomposed with a half-life of 0.5 hours. The main decomposition products include dimethylnitramine, dimethylformamide, formaldehyde and carbon monoxide (Tuazon et al. 1978). The nitrosation of dimethylamine has been described in detail elsewhere (Henschler 1984). Dimethylnitrosamine is found regularly as an impurity ( mg/kg) in samples of liquid dimethylamine (Spiegelhalder et al. 1978). 1.2 Pharmacokinetics Dimethylamine is a biogenic amine and can be detected in the urine of man and other mammals; it is produced in the metabolism of choline and choline-containing phosphatides (Asatoor and Simenhoff 1965, Asatoor et al. 1967, Blau 1961). Orally administered dimethylamine is excreted largely unchanged (Dargel 1966). Analysis of air and urine was carried out during a period of 24 hours in a factory processing dimethylamine; the workplace air contained not only dimethylamine and methyl-amine but also highly variable amounts of ethylamine, methylisobutylamine and methylisopropylamine which never amounted to more than one twentieth of the average dimethylamine concentration. At the workplaces in this factory the dimethylamine concentrations varied between 1.2 and 34 mg/m 3 and the methyl-amine between 0.7 and 37 mg/m 3. Before the beginning of the shift the levels of urinary amines were the same in the exposed and the control groups. Whereas the urine values in the control group remained practically unchanged during the course of the day, in the exposed persons there was a marked increase, especially in the excretion of dimethylamine which rose after only a short period of exposure from about 18 mg/l to 65 mg/l. The urine levels did not return to the pre-exposure values within 24 hours. The authors considered these findings to be of significance because of the danger of cumulative effects and the possibility of nitrosamine formation during simultaneous exposure to nitrogen oxides (Bittersohl and Heberer 1980). Thus the metabolism of dimethylamine differs markedly from that of methyl-amine and trimethylamine. In the animal, methylamine is broken down almost completely (Rechenberger 1940); trimethylamine is mostly N-oxidized and excreted as trimethylamine oxide (Lintzel 1934).

3 Volume 7 Dimethylamine 77 After intravenous injection of 250 µg radioactively labelled dimethylamine into rats, half of the radioactivity had vanished from the blood after 12.5 minutes; after 15 minutes, secretion of dimethylamine from the blood into the intestines was observed. The reabsorption from the intestine led to a second dimethylamine peak in the blood 25 minutes after the injection; the second half-life in plasma was 15.2 minutes (Ishiwata et al. 1984). After exposure of F344 rats for 6 hours to chromatographically purified 14 C- dimethylamine at a concentration of 10 or 175 ml/m 3, the plasma radioactivity was seen to decrease biphasically. The half-times were given as αt 1 2 = 1 2 hours and βt = hours. Immediately after the exposure, the level of radioactivity in the mucous membranes of the upper respiratory tract was two orders of magnitude larger than that in any other tissue; 72 hours after the end of exposure most of the radioactivity (90.5 %) was found in urine and faeces as unchanged dimethylamine, and the tissues contained 7%to8%.Onlyaverysmallfractionofthedose(1.5%)wasexhaledasCO 2 (McNulty and Heck 1983). After ingestion of dimethylamine (23.6 ppm in the diet) by Wistar rats, the substance was shown to be poorly absorbed in the stomach and readily absorbed in the intestinal tract (U stomach 198 minutes, t 1 2 intestines minutes) (Ishiwata et al. 1984). The metabolism of dimethylamine in the respiratory and olfactory epithelia of rats was studied in vitro in microsomal preparations and in vivo in animals which had inhaled 10 or 175 ml/m 3 for 6 hours; the production of 14 C-formaldehyde and the subsequent 14 C-incorporation into macromolecules could be demonstrated. The rate of metabolism was significantly higher in the olfactory epithelium than in the respiratory epithelium (McNulty et al. 1983). It was calculated that about 8 % of the dimethylamine dose was metabolized to formaldehyde (McNulty and Heck 1983). In vitro in rat liver cells and in mouse macrophages, dimethylamine is taken up and stored by acidic vacuoles such as lysosomes; this results in osmotic enlargement of the vacuoles and inhibition of the normal lysosomic protein degradation processes (Okhuma and Poole 1981, Seglen and Gordon 1980). It is not known whether this effect is of significance in vivo. 2 Effects in Man 2.1 Acute toxicity The odour thresholds which have been published for dimethylamine are shown in Table 1. A test person ingested 8 g dimethylamine hydrochloride and tolerated it well. One day later, 91.5 % of the dose had been excreted in the urine (Rechenberger 1940). 2.2 Effects on skin and mucous membranes In data sheets for dimethylamine, the producers warn that the substance is highly caustic, even dilute solutions causing "chemical burns". In addition to penetrating the skin so readily, liquid short-chain secondary monoamines are able to alter the skin structure so

4 78 Dimethylamine Volume 7 Table 1. Published odour thresholds for dimethylamine Odour threshold (ml/m 3 ) Medium References air Oelert and Florian air Leonardos et al air Amoore and Hautala air Oelert and Florian water Amoore and Forrester water Dzhanashvili 1967 that it becomes permeable to substances which can normally not be absorbed (NIOSH 1981). It is not known whether or to what extent gaseous dimethylamine can penetrate the skin. Therefore the substance is not designated with an "H". Several authors have reported without any other details that amine production workers suffer from hazy vision (glaucopsy). Such reversible visual disorders are said to be induced by dimethylamine vapour (Mellerio and Weale 1966, Munn 1967). Other authors (Friemann and Overhoff 1956, Graf 1961) describe a consistent set of symptoms of eye damage in persons exposed briefly or for longer periods to vapours of dimethylamine or trimethylamine or occasionally to aerosols: conjunctival irritation, red and swollen eyelids, swelling and later clouding of the cornea, keratitis. The damage can persist for days or months, depending on its severity, and is associated not only with pronounced visual impairment but also with severe pain. Long-term exposure of workers to low concentrations of dimethylamine vapour resulted not only in conjunctivitis but also in dermatitis (Air Products and Chemicals Inc. 1978). 2.3 Subchronic and chronic toxicity In a series of inhalation studies, five test persons aged between 25 and 35 years were exposed in a pressure chamber at 308 mm Hg, 20 ± 2 C and 40 % to 60 % humidity during a cycle of 40 minutes work and 20 minutes rest with an energy output of 400 kcal/hour. In the first series (control) the persons inhaled pure oxygen, in the second and third series a mixture of oxygen with dimethylamine at concentrations of 1 or 3 mg/m 3 (0.5 or 1.5 ml/m 3 ). The exposures were carried out on five consecutive days each week for up to 6 hours daily for a period of 15 days. At the high dimethylamine concentration, pulse rates increased during both the work and rest periods from exposure day 2; there was a tendency to lower systolic blood pressure which persisted for the whole 15 day period. The ECG data for this group of test persons were comparable with the control data. The parameter "vigilance of the visual analyser" proved to be labile in the exposed persons. Repeated inhalation of dimethylamine concentrations of 3 mg/m 3 frequently resulted in tremor. At this concentration both reduction and increase in blood catalase activity, a considerable increase in blood serum cholinesterase activity and a decrease in the ascorbic acid level in blood were found. Inhalation of 1 mg/m 3 had no effect on the tested parameters (Sedov et al. 1980). This publication is very difficult to assess for the following reasons: the methods used are not described in detail nor made available by literature

5 Volume 7 Dimethylamine 79 references. The experimental data are not given. The parameters which are affected are almost all unspecific and cannot form the basis of a specific toxicological assessment. There are no studies on allergenic effects of dimethylamine. Carcinogenicity studies with the substance have not been carried out. 3EffectsonAnimals 3.1 Acute toxicity Inhalation For rats which had inhaled dimethylamine for 4 or 6 hours, LC 50 values of 4700 and 4540 ml/m 3, respectively, were obtained; for mice which inhaled dimethylamine for 2hours, the LC 50 value was 7650 ml/m 3 (see Table 2). After as little as one hour exposure, laboured breathing, restlessness or apathy and convulsions were seen. Particularly marked were signs of irritation of the exposed mucous membranes of the mouth, nose and eyes. In addition to mucosal haemorrhage, marked salivation, nasal secretion, mucosal erythema, lacrimation and spasmodic closing of the eyes were observed. The average survival period was 4.7 days. Symptoms of broncho-pneumonia persisted for 8 to 14 days and were clearly dose-dependent (Koch et al. 1980). Pathological examination of 43 rats which died 2 to 18 days after exposure revealed most frequently emaciation and inflammatory changes in the lungs in the form of bronchitis and bronchopneumonia (74 % of animals). In addition, various degrees of fatty degeneration of the peripheral lobules of the liver were found, slight degeneration of the liver parenchyma, kidney changes in the form of lower nephron nephrosis and slight granular degeneration of the heart muscle fibres. In 41 rats which survived the dimethylamine intoxication and were killed by decapitation 41 to 48 days post expositionem, no pathological anatomical changes could be found (Johannsen et al. 1980). The irritant effects of dimethylamine on the respiratory epithelium caused reflex respiratory depression; the RD 50 values (concentration producing a 50 % reduction in respiration rate) after exposure of rats and mice for 10 minutes were determined as 573 ml/m 3 and 511 ml/m 3, respectively (Buckley et al. 1984, Steinhagen et al. 1982). In another study the RD 50 value for mice exposed for 15 minutes was given as 70 ml/m 3 (Gagnaire et al. 1989) lngestion The oral LD 50 for dimethylamine in rats was found to be about 700 mg/kg body weight, in mice about 320 mg/kg and in guinea pigs and rabbits 240 mg/kg. In neutralized form (ph 8.0) the substance was less toxic, having LD 50 values of 8100 mg/kg body weight in rats, 1070 mg/kg in guinea pigs and 1600 mg/kg in rabbits (Table 2).

6 80 Dimethylamine Volume 7 Table 2. Acute toxicity of dimethylamine Species Administration route LD 50 mg/kg bw LC 50 ml/m 3 References rat inhalation (4 h) 4700 ( ) Koch et al rat inhalation (6 h) 4540 Steinhagen et al mouse inhalation (2 h) 7650 Steinhagen et al rat oral (base) (ph 8) Dzhanashvili 1967 mouse oral 316 (base) Dzhanashvili 1967 guinea pig oral rabbit oral bw body weight (base) (ph 8) (base) (ph 8) Dzhanashvili 1967 Dzhanashvili 1967 The effects of ingested dimethylamine included excitement and subsequent lethargy, lateral position and coordination disorders. Severe irritation of the mucous membranes was seen as well as extensive bleeding of the stomach walls and in the intestines of animals which died (Dzhanashvili 1967) Effects on skin and mucous membranes Erythema, swelling and finally ulceration of rabbit skin developed after contact with 3 % to 6 % aqueous solutions of dimethylamine (single applications). Treatment of mouse skin (tip of the tail dipped for 2 hours into a 6 % solution), on the other hand, led to a sharply defined hyperaemic area with subsequent tissue necrosis (gangrene) (Kremneva and Sanina 1961). Direct contact with dimethylamine vapour or with aqueous solutions results in concentration-dependent damage to skin and mucous membranes; the damage can be particularly severe in the eyes. Solutions containing as little as 1 % dimethylamine applied to the rabbit eye caused photophobia, blepharospasm, conjunctivitis, conjunctival oedema, keratitis and clouding of the cornea after a latent period of up to 6 days. Solutions of 5 % dimethylamine or more caused severe damage (vascularization and clouding of the cornea) which persisted for up to 28 days (Friemann and Overhoff 1956). Higher concentrations applied to the rabbit eye caused whitish-blue discolouration and translucence of the cornea after only a few seconds (Mellerio 1966).

7 Volume 7 Dimethylamine Subchronic and chronic toxicity Inhalation Exposure of F344 rats to a dimethylamine concentration of 175 ml/m 3, 6 hours daily for 1, 2, 4 or 9 days, led after one day to impairment of mucociliary clearance in the respiratory tract, to changes in the direction of mucous flow (reversal, whirlpool-like patterns), ciliostasis and mucostasis. The mucostasis was not always accompanied by histologically detectable tissue damage. Histological changes were most pronounced in the anterior region of the nose. Focal inflammation and necrosis of the squamous epithelium was accompanied by accumulation of neutrophils in the underlying connective tissue. In the olfactory epithelium after one and two days of exposure, severe vacuolation was seen in the olfactory sensory cells of the dorsal nasal passages and after 4 and 9 days exposure loss of olfactory cells and olfactory nerve bundles (Gross et al. 1987). Exposure of mice to 511 ml/m 3, 6 hours daily for 5 days, resulted in mild metaplasia of the squamous respiratory epithelium, moderately severe degeneration of the olfactory nerves and severe exfoliation, erosion, ulceration and necrosis of the respiratory and olfactory epithelia (Buckley et al. 1984). In rats which inhaled dimethylamine vapour in concentrations of 10, 30 or 100 ml/m 3, 6 hours daily, 5 days per week for 90 days, food consumption, body weight, mortality, clinical symptoms, haematological, clinical-chemical and urinary parameters, and pathological changes were investigated. Slight statistically significant changes in haematological and clinical chemical parameters were not considered to be caused by the exposures. Pathological examination of 44 types of tissue including brain, lungs and nasal conchae revealed no exposure-related damage (Mitchell et al. 1982). A group of 15 rats, 15 guinea pigs, 3 rabbits, 2 dogs and 3 monkeys were all exposed together in a large chamber for a period of 90 days to a dimethylamine concentration of 9±1mg/m 3 (5 ml/m 3 ). The continuous exposure was discontinued only very briefly (< 2.2 % of the time) to feed the animals and clean the cages. None of the exposed animals died. There were no symptoms of toxicity. The haematological and clinicalchemical parameters were normal (urea, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase and lactate dehydrogenase). Histological examination revealed inflammatory changes in the pulmonary interstitial tissue in all species, bronchus dilation in 3 rabbits and 2 of the 3 monkeys but no substance-specific histopathological changes (Coon et al. 1970). In an unpublished study carried out in 1964, a group of 10 rats, 6 guinea pigs and 2 rabbits (male and female), 5 mice (female) and one monkey (male) was exposed to dimethylamine concentrations of 97 ml/m 3 (180 mg/m 3 ) or 183 ml/m 3 (340 mg/m 3 ), 7 hours daily, 5 days per week for 18 to 20 weeks. After 9 days, corneal damage developed in guinea pigs and rabbits. In all species apart from the monkeys, centrilobular fatty degeneration of the hepatocytes and necrosis of liver parenchyma cells were observed. Degeneration of the testis tubules was seen in the high dose group rabbits and the low dose group monkeys (Hollingsworth and Rowe 1964).

8 82 Dimethylamine Volume lngestion After administration of dimethylamine hydrochloride doses of 110 or 220 mg/kg body weight alone and in combination with NaNO 2 doses of 110 mg/kg to groups of 8 male Wistar rats, daily for 30 days, no signs of liver or kidney toxicity were found. Only in the highest dose group (NaNO mg/kg plus dimethylamine hydrochloride 220 mg/kg) was ascites found in 3 animals and mild liver damage in one (Garcia-Roché et al. 1983). In 5 male rats given dimethylamine in the drinking water for 72 days in daily doses of about 94 mg/kg body weight, microscopic examination revealed focal macrophage aggregations in the lungs and, in 2 animals, slight metaplasia of the bronchial squamous epithelium (Kimbrough and Sedlak 1968). Dimethylamine hydrochloride was administered orally to guinea pigs in doses of 0.035, 0.35 and 3.5 mg/kg body weight and to rats in doses of 0.007, and 0.35 mg/kg body weight (daily? details not clear) for a period of 8 months. In the high dose group guinea pigs, the coproporphyrin excretion in the urine, the blood urea level and the relative liver weights were increased and the vitamin C level in the adrenal cortex decreased. There were no effects on blood haemoglobin or methaemoglobin levels, erythrocyte or leukocyte counts, blood cholinesterase activity or phagocytotic activity of the leukocytes. Histological examination of the animals at the end of the study revealed no substance-related effects. In the rats, the 0.35 and mg/kg body weight doses caused changes in the conditioned reflexes. Administration of 0.35 mg/kg reduced the phagocytotic activity of the rat leukocytes and increased the relative liver weights. No effects were seen in the low dose group (Dzhanashvili 1967). These changes are not considered to reflect adverse effects of the substance on health Intraperitoneal injection Intraperitoneal administration of dimethylamine doses of 250 mg/kg body weight, daily for 4 days, reduced the cytochrome P450 levels in the liver microsomes of mice and reduced the rate of dimethylamine N-dealkylation without affecting the N-oxidation of dimethylamine. Histological examination of the liver revealed fatty infiltration and single cell necrosis. None of these effects was observed after doses of 25, 50 or 125 mg/kg body weight administered daily for 4 days (Wirth and Thorgeirsson 1978). The authors considered that the cytochrome P450-dependent N-dealkylating monooxygenase of the mouse liver is more sensitive to the hepatotoxic effects of dimethylamine than is the N-oxidizing monooxygenase. 3.3 Allergenic effects In a test for sensitization with groups of 11 guinea pigs (patch test of Magnusson and Kligman), induction with a 0.5 M solution (50 mg dimethylamine) and provocation after 72 hours with a 0.5 M or 0.05 M dimethylamine solution produced positive reactions in all animals and in 9 of the 11, respectively (Kantoh et al. 1985).

9 Volume 7 Dimethylamine 83 Since the data base is inadequate and since no sensitization of humans handling dimethylamine has been observed to date, it does not seem to be justified to designate the substance with an "S". 4 Reproductive and Developmental Toxicity After intraperitoneal injection of dimethylamine doses of 13.7, 45.9 or mg/kg body weight into groups of 12 pregnant Swiss mice on day 8 post conceptionem, gross pathological examination (implantation losses, foetal weight, litter size, placental weight, body weights of the dams) on day 18 post conceptionem revealed no toxic effects on dams or foetuses (Varma et al. 1990). 5 Genotoxicity The results which have been obtained in studies of the genotoxic effects of dimethylamine are summarized in Table 3. In the absence of nitrite, dimethylamine was not mutagenic in a number of in vitro tests in Salmonella typhimurium, Escherichia coli or Saccharomyces cerevisiae with or without metabolic activation nor in the HPRT test in CHO cells. An exception was the Ames Salmonella-microsome test with strain TA1530 in which dimethylamine was a weak mutagen after metabolic activation. The authors considered that this finding requires further investigation. In hamster lung fibroblasts (CHL cells) in vitro, neither chromosomal aberrations nor sister chromatid exchange was observed with or without metabolic activation. An in vivo test for structural chromosomal aberrations in bone marrow cells (metaphase) of rats exposed for 3 months to dimethylamine concentrations of 0.5 or 1 mg/m 3 also yielded negative results. The authors' statement that the incidence of aneuploidy was significantly increased after 90 days in both concentration groups must be accepted with caution because of the methods employed (Isakova et al. 1971) and should be confirmed in a study which would allow reliable assessment of such effects. An in vitro UDS test in rat hepatocytes yielded negative results, but positive results after addition of nitrite. In host-mediated assays in rats and mice with S. typhimurium (G46, TA1534, TA1950, TA1951, TA1952), dimethylamine proved to be not mutagenic at the doses tested (for rat and mouse maximum dose 440 mg/kg body weight, oral) except when nitrite (c 150 mg/kg body weight) was administered simultaneously. The effect of nitrite isputdowntotheformationofnitrosodimethylamineinthestomachoftheexperimental animals. Nitrosodimethylamine is mutagenic in the mouse at doses of 0.2 mg/kg body weight or more and in the rat at doses of 0.6 mg/kg or more (Whong et al. 1979). Positive results were also obtained in another host-mediated assay with Schizosaccharomyces pombe in the mouse after oral nitrosodimethylamine doses of mg/kg body weight (Barale et al. 1981).

10 Table 3. Genotoxicity studies with dimethylamine 84 Test system Indicator organism Results References with S9 tests for gene mutation in vitro Ames test Salmonella typhimurium TA TA1531, TA1532, TA1964 Ames test S. typhimurium TA100, TA1535, TA1537, TA98 without S9 Green and Savage 1978 Zeiger et al Ames test S. typhimurium TA100, TA98 Kawachi et al reversion Escherichia coli Sd-4-73 Szybalski 1958 recombination Bacillus subtilis Kawachi et al petite mutants Saccharomyces cerevisiae canavanine resistance D B with Udenfriend's hydroxylation system Mayer 1971 HPRT test CHO cells Hsie et al tests for gene mutation in vivo host mediated assay host mediated assay mouse (800 mg/kg bw i.m.); S. typhimurium TA1534, TA1950, TA1951, TA1952; mutants determined in bacteria recovered by intraperitoneal lavage mouse, rat (440 mg/kg bw oral); mouse (66, 220, 440 mg DMA/kg bw or 160 mg NaNO 2 /kg bw); +* rat (220, 440 mg DMA/kg bw or 160 mg NaNO 2 /kg bw); S. typhimurium G46, mutants determined +* in bacteria recovered from liver tissue Green and Savage 1978 Whong et al Dimethylamine Volume 7

11 Table 3. (continued) Test system host mediated assay mouse (2000 mg DMA/kg bw mg NaNO 2 /kg bw, oral); S. typhimurium G46; mutants determined in bacteria recovered by intraperitoneal lavage +* Couch and Friedman 1975 tests for chromosomal damage in vitro chromosomal aberrations CHL cells Kawachietal.1980 chromosomal aberrations tests for chromosomal damage in vivo chromosomal aberrations tests for other end points CHL cells Ishidate and Odashima 1977 rat (3 months; 0.5, 1 mg/m 3 inhalation) examined 15 and 90 days after end of exposure Isakova et al UDS rat hepatocytes +* Martelli et al sister chromatid CHL cells Kawachietal.1980 exchange * in the presence of nitrite bw body weight Indicator organism Results with S9 without S9 References Volume 7 Dimethylamine 85

12 86 Dimethylamine Volume 7 6 Carcinogenicity Male and female F344 rats and B6C3F 1 mice were exposed to dimethylamine vapour at concentrations of 10, 50 or 175ml/m 3, 6 hours daily, 5 days per week for 24 months. From the second week of exposure to 175 ml/m 3, body weight gains were reduced significantly in the rats and less markedly in the mice. The only exposure-related changes were progressive, concentration-dependent nasal lesions in rats and mice of both sexes. Two regions were affected: the respiratory epithelium near the vestibule and along the dorsal edges of the nasal conchae and the olfactory epithelium in the dorsal nasal passages and sometimes in the more distal region of the nose. Local destruction of the anterior nasoturbinate and the nasal septum, local inflammation and squamous metaplasia of the respiratory epithelium were found in rats and mice, and goblet cell hyperplasia in the rat. In the olfactory epithelium there was a clear reduction in the number of sensory cells and olfactory nerves with enlargement of the Bowman glands and accumulation of eosinophilic material in the ducts of other adjacent glands. In the 175 ml/m 3 groups, these lesions were more marked in rats than in mice. Progression of the lesions between the 6-month and 12-month killings was minimal; however, in the 10 ml/m 3 group, there were slight changes in the olfactory epithelium in 7 of 30 animals after 12 months which had not been present after 6 months. The mucosal damage in the two species at the end of the study was described as focal and mild at 10 ml/m 3, moderate at 50 ml/m 3 and severe at 175 ml/m 3. No treatment-related increase in the incidence of neoplasms was seen (Swenberg 1990). 7 Manifesto (MAK value, classification) TheMAKvalueof10ml/m 3 (18 mg/m 3 ) which was valid until 1993 was established in line with the American threshold limit value to exclude mucosal irritation. However, two studies in which various animal species were exposed by inhalation demonstrate that pathological changes are to be expected at a dimethylamine concentration of 10 ml/m 3. Continuous exposure of animals of 5 species to a dimethylamine concentration of 9 mg/m 3 (5 ml/m 3 ) for 90 days did not produce symptoms of toxicity (Coon et al. 1970). Inhalation of 10, 30 or 100 ml/m 3, 6 hours daily, 5 days per week for 90 days did not produce exposure-related lesions in rats (Mitchell et al. 1982). After exposure of rats and mice to dimethylamine concentrations of 10, 50 or 175 ml/m 3, 6 hours daily, 5 days per week for 2 years, concentration-dependent lesions of the nasal epithelium developed. Lesions were not apparent after 6 months exposure at 10 ml/m 3 but were observed after 12 months exposure (Swenberg 1990). Since concentrations below 10 ml/m 3 have not yet been tested in a 2-year study and 10 ml/m 3 has been shown to produce mild mucosal damage, at least in rats, the MAK value was reduced in 1993 to 2 ml/m 3. It requires substantiation from experience of human exposures. As a substance with an intensive odour, dimethylamine is classified in category V for the limitation of exposure peaks (short term exposure level twice the MAK value, maximum duration 10 minutes, maximum frequency 4 times per shift).

13 Volume 7 Dimethylamine 87 Because of the inadequate data base, dimethylamine cannot be classified in one of the pregnancy risk groups and is listed in Section IIc. It should be remembered that dimethylamine can react with nitrogen oxides and nitrite to form mutagenic and carcinogenic nitrosamines and that the amine can contain the nitrosamine as an impurity. 8 References Air Products and Chemicals Inc.: Material Safety Data Sheet Dimethylamine, Allentown, PA, USA, 1978 Amoore, J. E., L. J. Forrester: "Specific anosmia to trimethylamine. The fishy primary odor", J.Chem. Ecol. 2, 49 (1976) Amoore, J. E., E. Hautala: "Odor as an aid to chemical safety: odor thresholds compared with threshold limit values and volatilities for 214 industrial chemicals in air and water dilution", J.Appl. Toxicol. 3, 212 (1983) Asatoor, A.M., M. J. Chamberlain, B. T. Emmerson, J. R. Johnson, A. J. Levi, M. D. Milne: "Metabolic effects of oral neomycin", Clin.Sci.33,111 (1967) Asatoor, A. M., M. L. Simenhoff: "The origin of urinary dimethylamine", Biochim. Biophys. Acta. (Amst) 111, 384 (1965) Barale, R., D. Zucconi, N. Loprieno: "A mutagenicity methodology for assessing the formation of N-dimethylnitrosamine in vivo", Mutat. Res. 85, 57 (1981) Bittersohl, G., H. Heberer: "Ergebnisse von Arbeitsplatz- und Urinanalysen bei Expositionen mit aliphatischen Aminen", Z. ges. Hyg. 26, 258 (1980) Blau, K.: "Chromatographic methods for the study of amines from biological material", Biochem. J. 80, 193 (1961) Buckley,L.A.,X.Z.Jiang,R.A.James,K.T.Morgan,C.S.Barrow:"Respiratorytractlesions induced by sensory irritants at the RD50 concentration", Toxicol. Appl. Pharmacol. 74,417 (1984) Coon, R. A., R. A. Jones, L. J. Jenkins jr., J. Siegel: "Animal inhalation studies on ammonia, ethylene glycol, formaldehyde, dimethylamine, and ethanol", Toxicol. Appl. Pharmacol. 16, 646(1970) Couch, D. B., M. A. Friedman: "Interactive mutagenicity of sodium nitrite, dimethylamine, methyl-urea and ethylurea", Mutat. Res. 31, 109 (1975) Dargel, R.: "Ausscheidung von Dimethylamin unter Zufuhr methylierter Stickstoffverbindungen", Acta Biol. Med. Germ. 16, 474 (1966) Dzhanashvili, G. D.: [Hygienic substantiation of the maximum permissible content of dimethylamine in water bodies], Gig. i Sanit. No. 6, 16 (1967) (translation) Friemann, W., W. Overhoff: "Keratitis als Berufserkrankung in der Ölheringsfischerei", Klin. Monatsbl. Augenheilk. 128, 425 (1956) Gagnaire, F., S. Azim, P. Bonnet, P. Simon, J. P. Guenier, J. de Ceaurriz: "Nasal irritation and pulmonary toxicity of aliphatic amines in mice", J. Appl. Toxicol. 9, 301 (1989) Garcia-Roché, M., T. Ballentilla, A. Castillo, V. Silva, Y. Cabrera: "The toxicity of the daily intake of nitrite and dimethylamine", Die Nahrung 27, 837 (1983) Glasson, W. A.: "An experimental evaluation of atmospheric nitrosamine formation", Environm. Sci. Technol. 13, 1145 (1979) Graf, K.: "Experimented Untersuchungen über die Schädlichkeit von Rotbarschgewebsflüssigkeit für das Kaninchenauge", Dtsch. Gesundh.-Wes. 16, 70 (1961) Green, N. R., J. R. Savage: "Screening of safrole, eugenol, their ninhydrin positive metabolites and selected secondary amines for potential mutagenicity", Mutat. Res. 57, 115 (1978) Gross, E. A., D. L. Patterson, K. T. Morgan: "Effects of acute and chronic dimethylamine exposure on the nasal mucociliary apparatus of F-344 rats", Toxicol. Appl. Pharmacol. 90, 359 (1987)

14 88 Dimethylamine Volume 7 Henschler, D. (Ed.): "Die Nitrosierung flüchtiger Amine am Arbeitsplatz", Gesundheitsschädliche Arbeitsstoffe. Toxikologisch-arbeitsmedizinische Begründungen von MAK-Werten, VCH Verlagsgesellschaft, Weinheim, 1984, also available in English in the present series in Occupational Toxicants Volume 1 Hollingsworth, R. L., V. K. Rowe: Chronic inhalation toxicity of dimethylamine for laboratory animals, Dow Chemical Company, Midland, MI, USA, 1964, cited in Swenberg (1990) Hsie, A. W, J. P. O'Neill, S. Sebastian: "Quantitative mutagenesis and mutagen screening with Chinese hamster ovary cells", Appl. Methods Oncol. 3, 89 (1980) Iqbal, Z. M., S. S. Epstein, I. S. Krull, U. Goff, K. Mills, D. H. Fine: "Kinetics of nitrosamine formation in mice following oral administration of trace-level precursors", IARC Sci. Publ.:No. 31, 169(1981) Iqbal, Z. M.: "DNA binding in organs of mice exposed to dimethylamine (DMA) by gavage and nitrogen dioxide (NO 2 ) by inhalation", Proc. Am. Assoc. Cancer Res. 27, 85 (1986) Isakova, G. K., B. Y. Ekshtat, Y. Y Kerkis: [The study of the mutagenic action of chemical substances in substantiation of hygienic standards], Gig. i Sanit. No. 11, 9 (1971) (translation) Ishidate, M., S. Odashima: "Chromosome tests with 134 compounds on Chinese hamster cells in vitro a screening for chemical carcinogens", Mutat. Res. 48, 337 (1977) Ishiwata, H., R. Iwata, A. Tanimura: "Absorption, secretion and excretion of dimethylamine in rats", IARC Sci. Publ. No. 57, 255 (1984) Johannsen, U., G. Mehlhorn, R. Kliche, R. Lang: "Untersuchungen zur Pathomorphologie der akuten aerogenen Dimethylaminintoxikation bei Ratten", Wiss. Z. Karl-Marx-Univ., Leipzig, Math.-Naturwiss. Reihe 29, 475 (1980) Kantoh, H., M. Ishihara, M. Itoh, K. Hosono, M. Nishimura: "Allergens in rubber products", Hifu 27, 501 (1985) Kawachi, T., T. Yahagi, T. Kada, Y. Tazima, M. Ishidate, M. Sasaki, T. Sugiyama: "Cooperative programme on short-term assays for carcinogenicity in Japan", IARC Sci. Publ. No. 27, 323 (1980) Kimbrough, R. D., V. A. Sedlak: "Lung morphology in rats treated with hexamethylphosphoramide", Toxicol. Appl. Pharmacol. 12, 60 (1968) Koch, R, G. Mehlhorn, R. Kliche, R. Lang: "Untersuchungen zur aerogenen Intoxikation bei Ratten durch Methylamine", Wiss. Z. Karl-Marx-Univ., Leipzig, Math.-Naturwiss. Reihe 29, 463 (1980) Kremneva, S. N., Y P. Sanina: "Toxicology of dimethylamine", Toksikol. Novykh. Prom. Khim. Veshchesv. 1, 41 (1961), cited in NIOSH (1981) Leonardos, G., D. Kendall, N. Barnard: "Odor threshold determinations of 53 odorant chemicals", J. Air Pollut. Contr. Ass. 19, 91 (1969) Lintzel, W: "Untersuchungen über Trimethylammoniumbasen. III. Mitteilung: Trimethylammoniumbasen im menschlichen Harn". Biochem. Z. 273, 243 (1934) Martelli, A., E. Fugassa, A. Voci, G. Brambilla: "Unscheduled DNA synthesis induced by nitrosated ranitidine in primary cultures of rat hepatocytes", Mutat. Res. 122, 373 (1983) Mayer, V. W: "Mutagenicity of dimethylnitrosamine and diethylnitrosamine for Saccharomyces in an in vitro hydroxylation system", Molec. Gen. Genet. 112, 289 (1971) McNulty, M. J., H. D. Heck: "Disposition and pharmacokinetics of inhaled dimethylamine in the Fischer 344 rat", Drug Metab. Dispos. 11, 417 (1983) McNulty, M. J., M. Casanova-Schmitz, H. D. Heck: "Metabolism of dimethylamine in the nasal mucosa of the Fischer 344 rat", Drug Metab. Dispos. 11, 421 (1983) Meier-Bratschi, A., W. K. Lutz, C. Schlatter: "Methylation of liver DNA of rat and mouse by N- nitrosodimethylamine formed in vivo from dimethylamine and nitrite", Food chem. Toxicol. 21, 285 (1983) Mellerio, J., R. A. Weale: "Hazy vision in amine plant operatives", Br.J.Ind.Med.23,153 (1966) Mitchell, R. I., K. L. Pavkov, W. D. Kerns, M. M. Connell: A 90-day inhalation toxicology study in rats exposed to dimethylamine, Chemical Industry Institute of Toxicology (CIIT) Docket No. 215N2, Research Triangle Park, NC, USA, 1982 Munn, A.: "Health hazard in the chemical industry", Trans. Soc. Occup. Med. 17, 8 (1967)

15 Volume 7 Dimethylamine 89 NIOSH (National Institute of Occupational Safety and Health): Secondary and tertiary aliphatic monoamines, Report No. 7, Contract No , Silver Spring, MA, USA, 1981 Oelert, H. H., T. Florian: "Erfassung und Bewertung der Geruchsbelästigung durch Abgase von Dieselmotoren", Staub-Reinhalt. Luft 32, 400 (1972) Okhuma, S., B. Poole: "Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances", J. Cell Biol. 90, 656 (1981) Pitts, J. N., D. Grosjean, K. van Cauwenberghe, J. P. Schmidt, D. R. Fitz: "Photooxidation of aliphatic amines under simulated atmospheric conditions: formation of nitrosamines, nitramines, amides, and photochemical oxidant", Environm. Sci. Technol. 12, 946 (1978) Rechenberger, J.: "Über die flüchtigen Alkylamine im menschlichen Stoffwechsel. II. Mitteilung: Ausscheidung im Harn nach oraler Zufuhr", Hoppe-Seylers Z. Physiol. Chem. 265, 275 (1940) Sedov, A. V., N. A. Surovtsev, G. E. Mazneva, O. N. Shevkun: [Materials for use in establishment of a maximum allowable concentration for dimethylamine in the gaseous medium of insulating means of individual protection], Gig. i Sanit. No. 2, 81 (1980) (translation) Seglen, P. O., P. B. Gordon: "Effects of lysosomotropic monoamines, diamines, amino alcohols, and other amino compounds on protein degradation and protein synthesis in isolated rat hepatocytes", Mol. Pharmacol. 18, 468 (1980) Spiegelhalder, B., G. Eisenbrand, R. Preussmann: "Verunreinigung von Aminen mit N-Nitrosaminen", Angew. Chem. 90, 379 (1978) Steinhagen, W. H., J. A. Swenberg, C. S. Barrow: "Acute inhalation toxicity and sensory irritation of dimethylamine", Am. Ind. Hyg. Assoc. J. 43, 411 (1982) Swenberg,J.A.:Twenty four month final report inhalation toxicity of dimethylamine in F344 rats and B6C3F1 mice, Chemical Industry Institute of Toxicology (CIIT) Docket No , Research Triangle Park, NC, USA, 1990 Szybalski, W.: "Special microbiological systems. II. Observations on chemical mutagenesis in microorganisms", Ann. N. Y. Acad. Sci. 76, 475 (1958) Tuazon, E. C., A. M. Winer, R. A. Graham, J. P. Schmidt, J. N. Pitts: "Fourier transform infrared detection of nitramines in irradiated amine-nox systems", Environm. Sci. Technol. 12, 954 (1978) Varma, D. R., I. Guest, S. Smith, S. Mulay: "Dissociation between maternal and fetal toxicity of methyl isocyanate in mice and rats", J. Toxicol. Environm. Health 30, 1 (1990) Whong, W.-Z., N. D. Speciner, G. S. Edwards: "Mutagenicity detection of in vivo nitrosation of dimethylamine by nitrite", Environm. Mutag. 1, 277 (1979) Wirth, P. J., S. S. Thorgeirsson: "Amine oxidase in mice sex differences and developmental aspects", Biochem. Pharmacol. 27, 601 (1978) Zeiger, E., B. Anderson, S. Haworth, T. Lawlor, K. Mortelmans, W. Speck: "Salmonella mutagenicity tests: III. results from the testing of 255 chemicals", Environ. Mutagen. 9, Suppl. 9, 1 (1987) completed

H 2 C CH 2 CH 2 CH 2 O 2 S O C 4 H 8 O 3 S. Classification/MAK value: see Section III A2) MAK List 1985 Classification/MAK value dates from: 1986

H 2 C CH 2 CH 2 CH 2 O 2 S O C 4 H 8 O 3 S. Classification/MAK value: see Section III A2) MAK List 1985 Classification/MAK value dates from: 1986 1,4-Butane sultone Classification/MAK value: Classification/MAK value dates from: 1986 Synonyms: Chemical name (CAS): see Section III B MAK List 1987 butanesultone δ-butane sultone δ-valerosultone butanesulfone

More information

5.15 HEXYTHIAZOX (176)

5.15 HEXYTHIAZOX (176) Hexythiazox 225 5.15 HEXYTHIAZOX (176) TOXICOLOGY Hexythiazox is the ISO approved name for (trans-5-(4-chlorophenyl)-n-cyclohexyl-4-methyl-2-oxo- 3-thiazolidine-carboxamide (CAS No. 78587-05-0). Hexythiazox

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/MRL/488/98-FINAL July 1998 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS DIETHYLENE GLYCOL MONOETHYL

More information

5.17 PENTHIOPYRAD (253)

5.17 PENTHIOPYRAD (253) Penthiopyrad 189 5.17 PENTHIOPYRAD (253) TOXICOLOGY Penthiopyrad is the International Organization for Standardization (ISO) approved name for N-[2- (1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide

More information

5.36 THIOPHANATE-METHYL (077)

5.36 THIOPHANATE-METHYL (077) 391 5.36 THIOPHANATE-METHYL (077) TOXICOLOGY is the International Organization for Standardization (ISO) approved common name for dimethyl 4,4 -(o-phenylene)bis(3-thioallophanate) (International Union

More information

Summary of Toxicity Studies on Imazapyr

Summary of Toxicity Studies on Imazapyr Summary of Toxicity Studies on Imazapyr Technical Department, Cyanamid (Japan) Ltd. (Received July 15, 1997 ; Accepted August 20, 1997) DESCRIPTIO OF THE TEST COMPOUD Imazapyr is a nonselective herbicide

More information

DICHLOROACETONITRILE. 1. Exposure Data

DICHLOROACETONITRILE. 1. Exposure Data DICHLOROACETONITRILE Data were last evaluated in IARC (1991). 1. Exposure Data 1.1 Chemical and physical data 1.1.1 Nomenclature Chem. Abstr. Serv. Reg. No.: 3018-12-0 Chem. Abstr. Name: Dichloroacetonitrile

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/MRL/114/96-FINAL June 1996 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS EPRINOMECTIN SUMMARY REPORT

More information

formic acid ethyl ester

formic acid ethyl ester Formic acid ethyl ester MAK value (1961) 100 ml/m 3 (ppm) 3.10 mg/m 3 Peak limitation (2000) Category I, excursion factor 1 Absorption through the skin (1997) H Sensitization Carcinogenicity Prenatal toxicity

More information

(Z)-1-Chloro-2,3,3,3-tetrafluoropropene (2017)

(Z)-1-Chloro-2,3,3,3-tetrafluoropropene (2017) WORKPLACE ENVIRONMENTAL EXPOSURE LEVEL (Z)-1-Chloro-2,3,3,3-tetrafluoropropene (2017) I. IDENTIFICATION Chemical Name: (Z)-1-Chloro-2,3,3,3-tetrafluoropropene Synonyms: HCFO-1224yd(Z) CAS Number: 111512-60-8

More information

Dichlorvos DICHLORVOS (025)

Dichlorvos DICHLORVOS (025) Dichlorvos 63 5.7 DICHLORVOS (025) TOXICOLOGY Dichlorvos is the International Organization for Standardization (ISO) approved common name for 2,2-dichlorovinyl dimethyl phosphate (International Union of

More information

Hexane (all isomers except n-hexane)

Hexane (all isomers except n-hexane) Hexane (all isomers except n-hexane) Classification/MAK value: MAK value dates from: 1991 Synonyms: isohexane 200 ml/m 3 (ppm) 700 mg/m 3 2,3-dimethylbutane dimethylpropylmethane diethylmethylmethane ethyl-trimethylmethane

More information

Dithianon DITHIANON (180)

Dithianon DITHIANON (180) Dithianon 201 5.11 DITHIANON (180) TOXICOLOGY Dithianon (C 14 H 4 N 2 O 2 S 2 ) is the International Organization for Standardization (ISO) approved name for 5,10-dihydro-5,10-dioxonaphtho[2,3-b]-1,4-dithiine-2,3-dicarbonitrile

More information

Thiophanate-methyl -MATERIAL SAFETY DATA SHEET

Thiophanate-methyl -MATERIAL SAFETY DATA SHEET Thiophanate-methyl -MATERIAL SAFETY DATA SHEET 1. Chemical Product Identification Product Name: Thiophanate-methyl Molecular Formula: C 12 H 14 N 4 O 4 S 2 Molecular Weight: 342.4 Structural Formula: Chemical

More information

Nations, All rights reserved ANNEX 8 AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM

Nations, All rights reserved ANNEX 8 AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM ANNEX AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM Annex AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM A.1 Classification proposal The following classification proposal

More information

DIBROMOACETONITRILE. 1. Exposure Data

DIBROMOACETONITRILE. 1. Exposure Data DIBROMOACETONITRILE Data were last evaluated in IARC (1991). 1. Exposure Data 1.1 Chemical and physical data 1.1.1 Nomenclature Chem. Abstr. Serv. Reg. No.: 3252-43-5 Chem. Abstr. Name: Dibromoacetonitrile

More information

Cycloxydim CYCLOXYDIM (179)

Cycloxydim CYCLOXYDIM (179) Cycloxydim 125 5.9 CYCLOXYDIM (179) TOXICOLOGY Cycloxydim is the ISO approved name for (5RS)-2-[(EZ)-1-(ethoxyimino)butyl]-3-hydroxy-5-[(3RS)- thian-3-yl]cyclohex-2-en-1-one (IUPAC). The CAS chemical name

More information

Concepts of Biological Limit Values (BAT Values, EKA and BLW)

Concepts of Biological Limit Values (BAT Values, EKA and BLW) Concepts of Biological Limit Values (BAT Values, EKA and BLW) The BAT Concept Biological Tolerance Value for Occupational Exposures (Biologischer Arbeitsstoff-Toleranz-Wert) Definition The BAT value (

More information

ANNEX 8 AN EXAMPLE OF CLASSIFICATION IN THE

ANNEX 8 AN EXAMPLE OF CLASSIFICATION IN THE ANNEX 8 AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM - 427 - Annex 8 AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM A8.1 Classification proposal The following classification

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/MRL/527/98-FINAL January 1999 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS AZAMETHIPHOS SUMMARY REPORT

More information

Chloroacetic acid methyl ester H, S

Chloroacetic acid methyl ester H, S Chloroacetic acid methyl ester H, S Classification/MAK value: MAK value dates from: 1994 Synonyms: Chemical name (CAS): CAS number: 96-34-4 Structural formula: 1 ml/m 3 (ppm) 5mg/m 3 peak limitation category

More information

ENVIRONMENTAL TOXICOLOGY

ENVIRONMENTAL TOXICOLOGY ENVIRONMENTAL TOXICOLOGY Chapter 4 Toxicokinetics Mohd Amir Bin Arshad Toxicokinetics study on how a substance gets into the body and what happens to it in the body" The kinetics (movement) of substances

More information

Summary. Scope. Physical and chemical properties

Summary. Scope. Physical and chemical properties Summary Scope At request of the Minister of Social Affairs and Employment, The Health Council of the Netherlands sets health-based recommended occupational exposure limits (HBR-OEL) for toxic substances

More information

HYDROGEN PEROXIDE HUMAN HEALTH EFFECTS. CAS No.: EINECS No.: REPORT VERSION: Draft of 24 April 2001

HYDROGEN PEROXIDE HUMAN HEALTH EFFECTS. CAS No.: EINECS No.: REPORT VERSION: Draft of 24 April 2001 EUROPEAN COMMISSION DIRECTORATE-GENERAL HEALTH AND CONSUMER PROTECTION Directorate C - Scientific Opinions Unit C2 - Management of Scientific Committees; scientific co-operation and networks Scientific

More information

Executive summary. Scope

Executive summary. Scope Executive summary Scope At the request of the Minister of Social Affairs and Employment, the Health Council of the Netherlands recommends health-based occupational exposure limits for the concentration

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/MRL/451/98-FINAL June 1998 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS BACITRACIN SUMMARY REPORT (1)

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology EMEA/MRL/754/00-FINAL July 2000 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS CEFACETRILE SUMMARY

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Global Manufacturing Pfizer Inc 235 East 42nd Street New York, NY 10017 Emergency telephone number: CHEMTREC

More information

5.24 TRIAZOLE FUNGICIDE METABOLITES

5.24 TRIAZOLE FUNGICIDE METABOLITES Triazole metabolites 355 5.24 TRIAZOLE FUNGICIDE METABOLITES TOXICOLOGY 1,2,4-Triazole, triazole alanine, triazole acetic acid, triazole pyruvic acid and triazole lactic acid are the common metabolites

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/MRL/606/99-FINAL June 1999 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS CYROMAZINE SUMMARY REPORT (1)

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 5 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

METHACRYLIC ACID CAS N :

METHACRYLIC ACID CAS N : FOREWORD INTRODUCTION CAS N : 79-41-4 UNEP PUBLICATIONS SIDS INITIAL ASSESSMENT PROFILE CAS No. 79-41-4 Chemical Name Methacrylic acid Structural Formula CH 2 =CH(CH 3 )-COOH RECOMMENDATIONS The chemical

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

Material Safety Data Sheet 47Industrial Park, Lilydale, Victoria 3140 Phone: Fax:

Material Safety Data Sheet 47Industrial Park, Lilydale, Victoria 3140 Phone: Fax: This substance is classified as Hazardous according to the criteria of Worksafe Australia. Not classified as Dangerous Goods according to the criteria of ADG code. 1. MATERIAL AND SUPPLY COMPANY IDENTIFICATION

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/MRL/503/98-FINAL November 1998 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS BROMHEXINE SUMMARY REPORT

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 Emergency telephone number:

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology EMEA/MRL/499/98-FINAL September 1998 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS CEFACETRILE

More information

5.3 AZINPHOS METHYL (002)

5.3 AZINPHOS METHYL (002) 5.3 AZINPHOS METHYL (002) TOXICOLOGY Azinphos-methyl is the ISO approved common name for S-3,4-dihydro-4-oxo-1,2,3-benzotriazin-3- ylmethyl O,O-dimethyl phosphorodithioate (IUPAC) or O,O-dimethyl S-[(4-oxo-1,2,3-benzotriazin-

More information

IMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS PDE FOR CUMENE

IMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS PDE FOR CUMENE INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE DRAFT CONSENSUS GUIDELINE IMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS Released for

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/MRL/339/98-FINAL May 1998 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS VALNEMULIN SUMMARY REPORT 1.

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

Product: H12MDI (4,4 -Methylene dicyclohexyl diisocyanate; CAS No )

Product: H12MDI (4,4 -Methylene dicyclohexyl diisocyanate; CAS No ) February 013 Properties, Hazards and Safety Information for H1MDI* Product: H1MDI (4,4 -Methylene dicyclohexyl diisocyanate; CAS No. 514-30-1) Physical and chemical data Physical state liquid Colour colourless

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET MSDS Number : PD-004E 1/7 MATERIAL SAFETY DATA SHEET 1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION MANUFACTURER : FUJIFILM ELECTRONIC MATERIALS CO., LTD. 15TH ARAI BLDG. 19-20, JINGUHMAE 6-CHOME, SHIBUYA-KU,

More information

Safety Data Sheet European Format

Safety Data Sheet European Format Safety Data Sheet European Format Preparation Date 05-Jan-2007 Revision Date Revision Number 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Product Name Chemical Name Synonyms

More information

4. Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms

4. Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms 212 4. Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms 4.1 Deposition, retention, clearance and metabolism The absorption and distribution of indium is highly dependent on its

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET MATERIAL SAFETY DATA SHEET SECTION 1 - IDENTIFICATION OF PRODUCT AND COMPANY Pfizer Inc Pfizer Animal Health 235 East 42nd Street New York, NY 10017 Trade names Ultrabac 7 Emergency telephone Hours of

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET MATERIAL SAFETY DATA SHEET 1. IDENTIFICATION OSTREM CHEMICAL CO. LTD. Phone: 780-440-1911 or 780-446-0177 2310-80 AVENUE In Case of Emergency Only: EDMONTON AB T6P 1N2 phone CANUTEC at (613) 996-6666 Product

More information

Recommendation from the Scientific Committee on Occupational Exposure Limits for Diphenyl ether

Recommendation from the Scientific Committee on Occupational Exposure Limits for Diphenyl ether Recommendation from the Scientific Committee on Occupational Exposure Limits for Diphenyl ether SCOEL/SUM/182 December 2012 Table of Contents 1. Substance identification, physico-chemical properties...

More information

HC RED NO Exposure Data H2N~NH-CH2-CH2-0H N02. (d) Solubilty: Soluble in water (0.28% w/w), ethanol and acetone

HC RED NO Exposure Data H2N~NH-CH2-CH2-0H N02. (d) Solubilty: Soluble in water (0.28% w/w), ethanol and acetone HC RED NO. 3 1. Exposure Data 1.1 Chemical and physical data 1.1.1 Synonyms, structural and molecular data Chem. Abstr. Serv Reg. No.: 2871-01-4 Chem. Abstr. Name: 2-(( 4-Amino-2-nitrophenyl)amino )ethanol

More information

PRODUCT: Ethyl alcohol (denatured) CHEMICAL ABSTRACT NO.: Mixture. Ethyl alcohol ppm Flammable

PRODUCT: Ethyl alcohol (denatured) CHEMICAL ABSTRACT NO.: Mixture. Ethyl alcohol ppm Flammable MATERIAL SAFETY DATA SHEET ETHYL ALCOHOL (DENATURED) Section I - IDENTIFICATION PRODUCT: Ethyl alcohol (denatured) SYNONYMS: Denatured ethanol CHEMICAL FORMULA: C 2 H 5 OH CHEMICAL ABSTRACT NO.: Mixture

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET MATERIAL SAFETY DATA SHEET SECTION 1 - CHEMICAL PRODUCT & COMPANY IDENTIFICATION Pfizer Consumer Healthcare Pfizer Inc 201 Tabor Road Morris Plains, New Jersey 07950 Emergency telephone Hours of operation

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

TOXICITY DATA (continued): KETOCONAZOLE (continued): TDLo (Oral-Rat) 1760 mg/kg: female 1-21 day(s) after conception: Reproductive: Maternal Effects: other effects; Fertility: post-implantation mortality

More information

Version 0.1 Revision Date 06/02/2015 Print Date 06/02/2015

Version 0.1 Revision Date 06/02/2015 Print Date 06/02/2015 SECTION 1. PRODUCT AND COMPANY IDENTIFICATION Product name : Substance number : REL_11387 Chemical usage : Cleaning Compound Manufacturer or supplier's details Company : Chemetall US, Inc. Address : 675

More information

Material Safety Data Sheet. 1. Identification of the substance/mixture and of the company/undertaking

Material Safety Data Sheet. 1. Identification of the substance/mixture and of the company/undertaking Revision Date: 21.10.2010 Page: 1/7 1. Identification of the substance/mixture and of the company/undertaking Product name: KODAK Rapid Fixer, Working solution (paper) Product code: 1973247 - Working solution

More information

CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

CHEMICAL PRODUCT AND COMPANY IDENTIFICATION DATE PREPARED: JULY, 1999 DATE REVISED: JUNE 2004 BLUE GEL PRODUCTS MATERIAL SAFETY DATA SHEET CHEMICAL PRODUCT AND COMPANY IDENTIFICATION PRODUCT NAME PRODUCT CODE JACK FROST COOL ONLY GEL PACK 61115

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/MRL/769/00-FINAL January 2001 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS COUMAFOS SUMMARY REPORT

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/MRL/526/98-FINAL January 1999 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS APRAMYCIN SUMMARY REPORT

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Animal Health Pfizer Inc 235 East 42nd Street New York, NY 10017 Poison Control Center Phone: 1-866-531-8896

More information

SIAM 19, October 2004 SIDS INITIAL ASSESSMENT PROFILE SUMMARY CONCLUSIONS OF THE SIAR

SIAM 19, October 2004 SIDS INITIAL ASSESSMENT PROFILE SUMMARY CONCLUSIONS OF THE SIAR SIDS INITIAL ASSESSMENT PROFILE CAS No. 67-56-1 Chemical Name Methanol Structural Formula CH 3 OH SUMMARY CONCLUSIONS OF THE SIAR Human Health Toxicokinetics, Metabolism, and Distribution: Methanol is

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

Product: IPDI (Isophorone diisocyanate; CAS No )

Product: IPDI (Isophorone diisocyanate; CAS No ) November 2015 Properties, Hazards and Safety Information for IPDI* Product: IPDI (Isophorone diisocyanate; CAS No. 4098-71-9) Physical and chemical data Physical state liquid Colour colourless to yellowish

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

Correlation of Lethal Doses of Industrial Chemicals between Oral or Intraperitoneal Administration and Inhalation Exposure#

Correlation of Lethal Doses of Industrial Chemicals between Oral or Intraperitoneal Administration and Inhalation Exposure# Industrial Health 1998, 36, 273-281 Correlation of Lethal Doses of Industrial Chemicals between Oral or Intraperitoneal Administration and Inhalation Exposure# Takeshi HONMA* and Megumi SUDA Division of

More information

COCAM 3, October 2012 SIDS INITIAL ASSESSMENT PROFILE

COCAM 3, October 2012 SIDS INITIAL ASSESSMENT PROFILE SIDS INITIAL ASSESSMENT PROFILE Category Name Aryl Substituted Dialkyl Peroxides CAS No(s). 80-43-3 25155-25-3 Chemical Name(s) 1,1'-(Dioxydipropane-2,2-diyl)dibenzene (DCUP) [1,3(or 1,4)-Phenylenebis(1-methylethylidene)]bis[tert-butyl]

More information

MINIMS AMETHOCAINE EYE DROPS

MINIMS AMETHOCAINE EYE DROPS MINIMS AMETHOCAINE EYE DROPS NAME OF THE MEDICINE Amethocaine hydrochloride Synonyms: Tetracaine hydrochloride Structural formula: Chemical name: 2-(dimethylamino)ethyl 4-(butylamino)benzoate hydrochloride

More information

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

2. QUALITATIVE AND QUANTITATIVE COMPOSITION NAME OF THE MEDICINAL PRODUCT Skinoren 20 % cream 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 g Skinoren cream contains 200 mg (20 %) azelaic acid. For the full list of excipients, see section 6.1 List

More information

Section 1 - Product Information. Section 2 - Composition/Information on Ingredient. Section 3 - Hazards Identification. Product Name GOSSYPOL

Section 1 - Product Information. Section 2 - Composition/Information on Ingredient. Section 3 - Hazards Identification. Product Name GOSSYPOL Section 1 - Product Information Product Name GOSSYPOL Product Number ST065835 Supplier: TimTec LLC www.timtec.net info@timtec.net Section 2 - Composition/Information on Ingredient Substance Name CAS #

More information

M A T E R I A L S A F E T Y D A T A S H E E T

M A T E R I A L S A F E T Y D A T A S H E E T M A T E R I A L S A F E T Y D A T A S H E E T FMOM No.: 9101-1MM-0.03 DATE: 5/21/99 PRODUCT NAME: Ethambutol HCl Tablet Cores POTENCY: 400 mg BATCH SIZE: 1,000,000 Cores ETHAMBUTOL HYDROCHLORIDE CAS #74-55-5

More information

Table of Contents. 1. Occurrence/use Health Significance... 4 Recommendation... 5 Key Bibliography... 6

Table of Contents. 1. Occurrence/use Health Significance... 4 Recommendation... 5 Key Bibliography... 6 Recommendation from the Scientific Expert Group on Occupational Exposure Limits for pentane, isopentane and neopentane SEG/SUM/79 Table of Contents 1. Occurrence/use... 4 2. Health Significance... 4 Recommendation...

More information

GLYCIDALDEHYDE. 1. Exposure Data

GLYCIDALDEHYDE. 1. Exposure Data GLYCIDALDEHYDE Data were last reviewed in IARC (1976) and the compound was classified in IARC Monographs Supplement 7 (1987). 1. Exposure Data 1.1 Chemical and physical data 1.1.1 Nomenclature Chem. Abstr.

More information

P-Tert-Butylbenzoic Acid

P-Tert-Butylbenzoic Acid SECTION 1: IDENTIFICATION Product Name: P-tert-Butylbenzoic acid CAS Number: 98-73-7 Chemical Formula: C11H14O2 Synonyms: PTBBA; 4-tert-Butylbenzoic acid Company Business Contact Silver Fern Chemical,

More information

SECTION (2): HAZARDOUS INGREDIENTS Range % (by weight) SECTION (3): PHYSICAL DATA (Typical values. May vary from sample to sample)

SECTION (2): HAZARDOUS INGREDIENTS Range % (by weight) SECTION (3): PHYSICAL DATA (Typical values. May vary from sample to sample) MATERIAL SAFETY DATA SHEET MANUFACTURER: MAXIM CHEMICAL INTERNATIONAL LTD. 1305 HALIFAX STREET, REGINA, SK S4R 1T9 PHONE: (306) 347-0444 SECTION (1): PRODUCT IDENTIFICATION AND USE PRODUCT NAME: OXALIC

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/MRL/300/97-FINAL November 1997 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS AZAPERONE SUMMARY REPORT

More information

MATERIAL SAFETY DATA SHEET GENERAL HYDROPONICS ph Up TM Dry Concentrate 3/12/09 SECTION 2. INGREDIENTS AND OCCUPATIONAL EXPOSURE LIMITS

MATERIAL SAFETY DATA SHEET GENERAL HYDROPONICS ph Up TM Dry Concentrate 3/12/09 SECTION 2. INGREDIENTS AND OCCUPATIONAL EXPOSURE LIMITS MATERIAL SAFETY DATA SHEET GENERAL HYDROPONICS ph Up TM Dry Concentrate SECTION 1. MATERIAL IDENTIFICATION Product Name: ph Up TM Dry Concentrate Chemical Family: Caustic alkali 3/12/09 Product Use: To

More information

Aspartame Material Safety Data Sheet

Aspartame Material Safety Data Sheet Newseed Chemical Co., Limited Material Safety Data Sheet MSDS SECTION 1- PRODUCT AND MANUFACTURER IDENTIFICATION Product Name: Manufacturer: Manufacturer s Address: China manufacturer Telephone: Fax: SECTION

More information

1,4-BENZOQUINONE (para-quinone) 1. Exposure Data

1,4-BENZOQUINONE (para-quinone) 1. Exposure Data 1,4-BENZOQUINONE (para-quinone) Data were last reviewed in IARC (1977) and the compound was classified in IARC Monographs Supplement 7 (1987). 1. Exposure Data 1.1 Chemical and physical data 1.1.1 Nomenclature

More information

Safety Data Sheet European Format

Safety Data Sheet European Format Safety Data Sheet European Format Preparation Date 09-Jan-2007 Revision Date Revision Number 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Product Name Common Name Chemical

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

Lecture 2 Chemical and Biological Agents

Lecture 2 Chemical and Biological Agents Lecture 2 Chemical and Biological Agents In the Chemical ad Biological section, Routes of exposure we will be covering: Forms of Chemical agents Examples of chemical agents Forms of Biological agents Classifications

More information

REVISION MATERIAL SAFETY DATA SHEET

REVISION MATERIAL SAFETY DATA SHEET REVISION MATERIAL SAFETY DATA SHEET 1 PRODUCT AND COMPANY IDENTIFICATION Product Name: PRESEPT* Disinfectant Tablets PRESEPT* Disinfectant Granules Chemical Composition: Contains Sodium dichloroisocyanurate

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

Material Safety Data Sheet Alkaline Iodide Azide Solution I. Section 1 - Chemical Product and Company Identification

Material Safety Data Sheet Alkaline Iodide Azide Solution I. Section 1 - Chemical Product and Company Identification An ISO9001 Certified Company Material Safety Data Sheet Section 1 - Chemical Product and Company Identification MSDS Name: Catalog Numbers: LC10670 Synonyms: None Company Identification: LabChem Inc 200

More information

ABLEBOND 8361J Adhesive Page 1 of 6 December 19, 05 *** MATERIAL SAFETY DATA SHEET *** 1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

ABLEBOND 8361J Adhesive Page 1 of 6 December 19, 05 *** MATERIAL SAFETY DATA SHEET *** 1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION ABLEBOND 8361J Adhesive Page 1 of 6 1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION PRODUCT NAME... ABLEBOND 8361J Adhesive SYNONYM NAME(S)... Modified Epoxy Resin Ablestik Laboratories Subsidiary of National

More information

MATERIAL SAFETY DATA SHEET SECTION (1): PRODUCT INFORMATION PRODUCT NAME: UCARTHERM CLEAR HEAT TRANSFER FLUID COMMON NAMES: THERMAL FLUID 17, PM-6195

MATERIAL SAFETY DATA SHEET SECTION (1): PRODUCT INFORMATION PRODUCT NAME: UCARTHERM CLEAR HEAT TRANSFER FLUID COMMON NAMES: THERMAL FLUID 17, PM-6195 MATERIAL SAFETY DATA SHEET SECTION (1): PRODUCT INFORMATION PRODUCT NAME: UCARTHERM CLEAR HEAT TRANSFER FLUID COMMON NAMES: THERMAL FLUID 17, PM-6195 CAS REGISTRY NUMBER: N/AP (mixture) CHEMICAL NAME:

More information

MATERIAL SAFETY DATA SHEET 3111 / 3113 / Canutec (24 hours) 1. CHEMICAL PRODUCT AND COMPANY INFORMATION

MATERIAL SAFETY DATA SHEET 3111 / 3113 / Canutec (24 hours) 1. CHEMICAL PRODUCT AND COMPANY INFORMATION 1. CHEMICAL PRODUCT AND COMPANY INFORMATION Product identification : 3111 / 3113 / 31116 Product name : Fine polishing compound Chemical family : Mixture Supplier / Manufacturer : Auto-Chem Inc. 33 de

More information

Safety Data Sheet. Isosorbide Mononitrate Extended Release Tablets 30 mg, 60 mg and 120 mg Oxycodone Hydrochloride Tablets 10mg

Safety Data Sheet. Isosorbide Mononitrate Extended Release Tablets 30 mg, 60 mg and 120 mg Oxycodone Hydrochloride Tablets 10mg Safety Data Sheet 1. IDENTIFICATION Products: Isosorbide Mononitrate Extended Release Tablets 30 mg, 60 mg and 120 mg Oxycodone Hydrochloride Tablets 10mg Recommended Use of the Chemical and Restrictions

More information

MINIMS OXYBUPROCAINE EYE DROPS

MINIMS OXYBUPROCAINE EYE DROPS MINIMS OXYBUPROCAINE EYE DROPS Name of Medicine: Oxybuprocaine Hydrochloride Description: Composition: Active. Benoxinate (oxybuprocaine) HCI USP. Inactive. Water Purified and Hydrochloric acid. No preservatives

More information

Safety Data Sheet. (Benzoic Acid) Section 1 Company Information. Section 2 Product Identification/ Information on Ingredients

Safety Data Sheet. (Benzoic Acid) Section 1 Company Information. Section 2 Product Identification/ Information on Ingredients Section 1 Company Information Parchem - fine & specialty chemicals 415 Huguenot Street New Rochelle, NY 10801 (914) 654-6800 (914) 654-6899 parchem.com info@parchem.com EMERGENCY RESPONSE NUMBER: CHEMTEL

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS European Medicines Agency Veterinary Medicines and Inspections EMEA/MRL/615/99-FINAL Rev.1 1 May 2008 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS 1-METHYL-2-PYRROLIDONE SUMMARY REPORT (2) 1. 1-Methyl-2-pyrrolidone

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

MATERIAL SAFETY DATA SHEET West System Inc.

MATERIAL SAFETY DATA SHEET West System Inc. MATERIAL SAFETY DATA SHEET West System Inc. 1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION PRODUCT NAME:... G5 Adhesive - Part A. PRODUCT CODE:... 865 CHEMICAL FAMILY:... Epoxy resin. CHEMICAL NAME:...

More information

SAFETY DATA SHEET (SDS)

SAFETY DATA SHEET (SDS) 1. PRODUCT AND COMPANY IDENTIFICATION SAFETY DATA SHEET (SDS) Product Name: Product Number: Formula: Product Use: Restrictions on Use: NaturaLyte (45X) (0000 through 4000 Series) None Solution: Acetic

More information

Material Safety Data Sheet

Material Safety Data Sheet Section 1. Chemical Product and Company Identification Material Safety Data Sheet Product Name: Triumph Version: V4 Effective Date: March 30, 2012 Supplier/ Manufacturer: Chemfax Products Ltd. 11444 42

More information

PRODUCT INFORMATION MINIMS OXYBUPROCAINE EYE DROPS NAME OF THE MEDICINE. Oxybuprocaine (benoxinate) hydrochloride. Chemical Structure

PRODUCT INFORMATION MINIMS OXYBUPROCAINE EYE DROPS NAME OF THE MEDICINE. Oxybuprocaine (benoxinate) hydrochloride. Chemical Structure PRODUCT INFORMATION MINIMS OXYBUPROCAINE EYE DROPS NAME OF THE MEDICINE Oxybuprocaine (benoxinate) hydrochloride Chemical Structure Chemical name: 2-Diethylaminoethyl-4-amino-3-butoxybenzoate hydrochloride

More information